AGC Inc.

TSE:5201 Lagerbericht

Marktkapitalisierung: JP¥1.4t

AGC Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

AGC wird ein jährliches Gewinn- und Umsatzwachstum von 11.2% bzw. 3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 7.3% betragen.

Wichtige Informationen

11.2%

Wachstumsrate der Gewinne

11.24%

EPS-Wachstumsrate

Building Gewinnwachstum7.5%
Wachstumsrate der Einnahmen3.0%
Zukünftige Eigenkapitalrendite7.31%
Analystenabdeckung

Good

Zuletzt aktualisiert22 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Analyseartikel • Nov 07

Earnings Update: AGC Inc. (TSE:5201) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Investors in AGC Inc. ( TSE:5201 ) had a good week, as its shares rose 6.4% to close at JP¥5,129 following the release...

Recent updates

Narrativ-Update • Apr 24

5201: Governance Shift And 2026 Outlook Will Support Measured Fair Share Pricing

Analysts have nudged their price target for AGC to ¥5,883.75, a modest adjustment that reflects slightly updated assumptions around discount rate, revenue growth, profit margin and future P/E while keeping their overall valuation view intact. What's in the News AGC issued consolidated earnings guidance for the first half of 2026, with expected net sales of ¥1,070,000 million and operating profit of ¥60,000 million for the period ending June 30, 2026 (company guidance).
Narrativ-Update • Apr 10

5201: Governance Shift And 2026 Earnings Guidance Will Support Fair Share Pricing

The analyst price target for AGC has been revised to ¥5,883.75. The modest adjustment reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E that analysts see as better aligning the valuation with current risk and return expectations.
Narrativ-Update • Mar 27

5201: Governance Changes And 2026 Earnings Guidance Will Keep Shares Fairly Priced

Analysts have adjusted AGC's fair value estimate from ¥5,946.25 to ¥5,883.75. This change reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions.
Narrativ-Update • Mar 12

5201: Governance Shift And Earnings Outlook Will Keep Shares Fairly Priced

Analysts have raised their price target on AGC from ¥5,608.75 to ¥5,946.25, citing updated assumptions related to revenue growth, profit margins, the discount rate, and future P/E expectations. What's in the News The Board of Directors meeting on February 6, 2026 resolved to propose partial amendments to the Articles of Incorporation at the March 27, 2026 Annual General Meeting of Shareholders, with the aim of transitioning AGC to a Company with Audit and Supervisory Committee (Key Developments).
Narrativ-Update • Feb 24

5201: Governance Overhaul And CFO Exit Will Keep Shares Looking Expensive

The analyst price target for AGC has shifted from ¥5,540 to ¥5,608.75, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E that analysts now factor into their models. What's in the News On February 6, 2026, the Board of Directors resolved to propose amendments to the Articles of Incorporation to transition AGC to a Company with Audit and Supervisory Committee, subject to approval at the 101st Annual General Meeting of Shareholders on March 27, 2026 (company announcement).
Neues Narrativ • Feb 20

Semiconductor And Mobility Trends Will Support Long-Term Demand For Advanced Materials

Catalysts About AGC AGC is a global materials company with businesses in glass, chemicals, electronics and life sciences. What are the underlying business or industry changes driving this perspective?
Narrativ-Update • Feb 09

5201: Governance Shift And Biologics Deals Will Leave Shares Looking Expensive

Analysts have lifted their price target on AGC from $5,327.50 to $5,540.00, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E as key inputs to the revised valuation. What's in the News AGC issued consolidated earnings guidance for the first half of 2026, with expected net sales of JPY 1,070,000 million and operating profit of JPY 60,000 million for the period ending June 30, 2026 (company guidance).
Narrativ-Update • Jan 26

5201: Governance Changes And Biologics Partnerships Will Support Steady Long Term Outlook

Analysts have modestly adjusted their price target on AGC to $5,327.50. This reflects small tweaks to assumptions on the discount rate, long term revenue growth, profit margin, and future P/E expectations.
Narrativ-Update • Jan 11

5201: Governance Shift And Biologics Partnerships Will Gradually Support Balanced Outlook

Analysts now place AGC's fair value at US$5,327.50, up modestly from US$5,302.50. This reflects slightly higher assumptions for revenue growth, profit margin and future P/E.
Narrativ-Update • Dec 27

5201: Governance Overhaul And Biologics Pipeline Will Steadily Shape Future Performance

Narrative Update on Analyst Price Target Analysts have modestly lifted their price target for AGC to $5,302.50, reflecting slight improvements in the company’s discount rate assumptions and long term profitability outlook. What's in the News AGC Inc.
Narrativ-Update • Dec 13

5201: Governance Shifts And Biologics Alliances Will Shape Future Performance

Analysts have modestly raised their price target on AGC to align with a fair value of $5,302.50. This reflects slightly higher assumptions for the discount rate and future earnings multiple, while keeping long term growth and margin expectations largely unchanged.
Narrativ-Update • Nov 28

5201: Earnings Outlook And Executive Changes Will Shape 2025 Performance

The analyst price target for AGC has increased by $337.50 to $5,302.50, as analysts revise their valuation based on updated financial metrics and outlook. What's in the News AGC Biologics announced a partnership with Repair Biotechnologies to develop a novel mRNA therapy aimed at reducing atherosclerotic plaques, addressing a leading cause of human mortality (Key Developments).
Narrativ-Update • Nov 14

5201: Revenue Stability And Leadership Shifts Will Define 2025 Outlook

Analysts have raised their price target for AGC from $4,883.75 to $4,965.00, citing modest improvements in expected revenue growth and profit margins. What's in the News AGC Inc.
Analyseartikel • Nov 07

Earnings Update: AGC Inc. (TSE:5201) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Investors in AGC Inc. ( TSE:5201 ) had a good week, as its shares rose 6.4% to close at JP¥5,129 following the release...
Narrativ-Update • Oct 31

5201: Panel Manufacturing Advances And Steady Metrics Will Shape Market Direction

Narrative Update on AGC: Analyst Price Target Change Analysts have maintained AGC's fair value estimate at $4,883.75, citing only minimal adjustments to key model inputs and reaffirming their previous outlook for the company. What's in the News AGC joined the 'JOINT3' consortium of 27 global companies, led by Resonac Corporation, to co-develop panel-level organic interposer technology and establish a prototype production line scheduled to begin operations in 2026 (Key Developments).
Analyseartikel • Oct 22

Is AGC (TSE:5201) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Narrativ-Update • Oct 17

Architectural Glass And Chemical Capacity Will Redefine Markets

Analyst Price Target for AGC Adjusted Slightly Amid Unchanged Fair Value Outlook Analysts have made a marginal downward revision to AGC's price target, now set at $4,883.75. This adjustment comes in response to minimal changes in the company’s underlying growth assumptions and profitability metrics.
Narrativ-Update • Oct 03

Architectural Glass And Chemical Capacity Will Redefine Markets

Analysts have raised AGC's price target from $4,758.75 to $4,883.75, citing minor adjustments to their growth and profitability assumptions that have led to a slightly higher valuation. What's in the News Resonac Corporation established the ‘JOINT3’ consortium with 26 other global leaders, including AGC, to develop advanced panel-level organic interposer technology for next-generation semiconductor packaging.
Analyseartikel • Sep 02

AGC's (TSE:5201) Returns On Capital Are Heading Higher

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Narrativ-Update • Aug 28

Architectural Glass And Chemical Capacity Will Redefine Markets

With no change in AGC’s consensus analyst price target, discount rate, or future P/E, analysts have maintained their fair value estimate at ¥4759. What's in the News AGC revised down full-year guidance citing production issues in biopharmaceuticals CDMO, lower PVC prices, semiconductor-related product weakness, and impairment losses from structural reforms in Colorado, reducing net sales, operating profit, and profit forecasts.
Analyseartikel • Aug 11

AGC's (TSE:5201) Earnings Offer More Than Meets The Eye

AGC Inc.'s ( TSE:5201 ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
User avatar
Neues Narrativ • Aug 03

Architectural Glass And Chemical Capacity Will Redefine Markets

Advancements in product offerings, manufacturing expansion, and strategic exits are set to improve AGC's margins, profitability, and growth capacity across core business segments.
Analyseartikel • Jul 18

Is AGC (TSE:5201) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyseartikel • Jun 25

AGC (TSE:5201) Has Affirmed Its Dividend Of ¥105.00

AGC Inc.'s ( TSE:5201 ) investors are due to receive a payment of ¥105.00 per share on 8th of September. This makes the...
Analyseartikel • Jun 10

AGC (TSE:5201) Will Pay A Dividend Of ¥105.00

The board of AGC Inc. ( TSE:5201 ) has announced that it will pay a dividend of ¥105.00 per share on the 8th of...

Gewinn- und Umsatzwachstumsprognosen

TSE:5201 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20282,322,160115,704102,400291,3675
12/31/20272,253,65099,07599,400305,7248
12/31/20262,188,23182,01256,725280,1278
3/31/20262,097,21385,36153,530272,099N/A
12/31/20252,058,83269,16264,931274,476N/A
9/30/20252,045,52051,85641,833255,137N/A
6/30/20252,047,88234,36341,156259,727N/A
3/31/20252,068,447-66,44220,311262,245N/A
12/31/20242,067,603-94,04242,456284,815N/A
9/30/20242,069,661-98,15233,718260,791N/A
6/30/20242,049,132-89,28039,700265,395N/A
3/31/20242,028,78622,77133,390250,004N/A
12/31/20232,019,25465,798-985212,546N/A
9/30/20232,020,841-44,366-21,468205,284N/A
6/30/20232,042,851-33,776-42,505183,546N/A
3/31/20232,052,415-11,625-47,345186,939N/A
12/31/20222,035,874-3,152-6,775217,146N/A
9/30/20221,962,72893,14949,549249,325N/A
6/30/20221,864,391131,19967,104280,712N/A
3/31/20221,776,485125,58194,349295,744N/A
12/31/20211,697,383123,840116,141326,713N/A
9/30/20211,633,040148,65386,579305,595N/A
6/30/20211,569,09385,11878,308282,918N/A
3/31/20211,448,36747,98547,691252,307N/A
12/31/20201,412,30632,71533,923225,392N/A
9/30/20201,407,05729,0583,531192,988N/A
6/30/20201,435,09523,58810,461201,335N/A
3/31/20201,513,92842,3489,643200,427N/A
12/31/20191,518,03944,434N/A191,906N/A
9/30/20191,520,50553,586N/A221,775N/A
6/30/20191,514,89473,752N/A210,872N/A
3/31/20191,512,05980,400N/A205,420N/A
12/31/20181,522,90489,593N/A189,287N/A
9/30/20181,525,72873,504N/A195,093N/A
6/30/20181,519,04279,812N/A194,279N/A
3/31/20181,500,65274,066N/A188,338N/A
12/31/20171,463,53269,225N/A203,504N/A
9/30/20171,406,62475,138N/A198,513N/A
6/30/20171,347,61057,948N/A193,573N/A
3/31/20171,309,91358,571N/A206,938N/A
12/31/20161,282,57047,438N/A203,637N/A
9/30/20161,276,59733,072N/A195,523N/A
6/30/20161,292,65935,955N/A195,236N/A
3/31/20161,308,69447,122N/A183,735N/A
12/31/20151,326,29342,906N/A187,170N/A
9/30/20151,343,71250,240N/A164,162N/A
6/30/20151,347,73246,205N/A151,506N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 5201Das prognostizierte Gewinnwachstum (11.2% pro Jahr) liegt über der Sparquote (0.8%).

Ertrag vs. Markt: 5201Die Erträge des Unternehmens (11.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (8.6% pro Jahr).

Hohe Wachstumserträge: 5201Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 5201Die Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt JP (5.3% pro Jahr).

Hohe Wachstumseinnahmen: 5201Die Einnahmen des Unternehmens (3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 5201Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (7.3%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/22 16:21
Aktienkurs zum Tagesende2026/05/22 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

AGC Inc. wird von 22 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Timothy LukeBarclays
Eric LeeBarclays
Alberto MoelBernstein